Weight-loss drugs shook up the stock market. Menopause treatments could be next.


Hims & Hers is taking aim at menopause and perimenopause in an attempt to tap in to a huge and potentially highly lucrative market.

You May Also Like

Large-cap ETFs seem expensive. Do I add them to our retirement accounts?

My husband, 58, and I, 53, have reached our highest-earning years. We…

Canary Wharf credit rating cut deeper into junk by Fitch

Canary Wharf Group’s credit has been cut further into junk territory by…

Spending in UK pubs tripled on day of Euro 2024 final, data shows

Spending in UK pubs, bars and clubs almost tripled on the day…

Alibaba founder Jack Ma urges staff to learn from rival Pinduoduo

Jack Ma has urged employees at Alibaba to learn from one of…